Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
CVMCA
|
Roger Sherwood Pratt
Director |
BUY
Grant, award, or other acquisition
|
Direct | 867 Added 4.84% |
-
|
Oct 01
2020 |
|
CVMCA
|
Ronald Lee Rayevich
Director |
BUY
Grant, award, or other acquisition
|
Direct | 867 Added 2.08% |
-
|
Oct 01
2020 |
|
EGIO
|
Robert A Lento
CEO |
SELL
Open market or private sale
|
Direct | 20,833 Reduced 1.12% |
$120,206
$5.77 p/Share
|
Oct 01
2020 |
|
EGIO
|
Robert A Lento
CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 20,833 Added 1.11% |
$37,083
$1.78 p/Share
|
Oct 01
2020 |
|
EGIO
|
Walter Amaral
Director |
SELL
Open market or private sale
|
Direct | 33,559 Reduced 10.91% |
$193,635
$5.77 p/Share
|
Oct 01
2020 |
|
EGIO
|
Walter Amaral
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 33,559 Added 9.84% |
$90,274
$2.69 p/Share
|
Oct 01
2020 |
|
CREX
|
David Arthur Bell
Director |
BUY
Grant, award, or other acquisition
|
Direct | 6,388 Added 18.93% |
-
|
Oct 01
2020 |
|
CREX
|
Donald A Harris
Director |
BUY
Grant, award, or other acquisition
|
Direct | 6,388 Added 5.29% |
-
|
Oct 01
2020 |
|
CREX
|
Dennis Mcgill |
BUY
Grant, award, or other acquisition
|
Direct | 6,388 Added 23.33% |
-
|
Oct 01
2020 |
|
CREX
|
Stephen Nesbit
Director |
BUY
Grant, award, or other acquisition
|
Direct | 6,388 Added 18.93% |
-
|
Oct 01
2020 |
|
LGIQ
|
Brent Suen
CEO |
BUY
Open market or private purchase
|
Direct | 2,000 Added 0.89% |
$12,800
$6.4 p/Share
|
Oct 01
2020 |
|
CLXT
|
Travis Frey
Chief Technology Officer |
BUY
Open market or private purchase
|
Direct | 150 Added 5.45% |
$820
$5.47 p/Share
|
Oct 01
2020 |
|
TOMZ
|
Nick Jennings
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 12,500 Added 50.0% |
$77,125
$6.17 p/Share
|
Oct 01
2020 |
|
TRT
|
A Charles Wilson |
BUY
Exercise of conversion of derivative security
|
Direct | 25,000 Added 7.24% |
$67,250
$2.69 p/Share
|
Oct 01
2020 |
|
SYPR
|
Anthony C Allen
VP and Assistant Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct | 7,883 Reduced 2.44% |
$8,514
$1.08 p/Share
|
Oct 01
2020 |
|
SYPR
|
Richard L Davis
SVP and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct | 7,883 Reduced 2.61% |
$8,514
$1.08 p/Share
|
Oct 01
2020 |
|
SYPR
|
Rebecca R Eckert
VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 3,436 Reduced 5.52% |
$3,711
$1.08 p/Share
|
Oct 01
2020 |
|
UAVS
|
Bret Chilcott
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 0.87% |
$110,000
$2.2 p/Share
|
Oct 01
2020 |
|
MDVL
|
Joseph Mannello
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 180,000 Added 10.3% |
-
|
Oct 01
2020 |
|
LMB
|
Jayme L. Brooks
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 10,280 Reduced 19.84% |
$110,202
$10.72 p/Share
|
Oct 01
2020 |
|
LMB
|
Jayme L. Brooks
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 42,215 Added 44.9% |
-
|
Oct 01
2020 |
|
ASGI
|
Nancy Yao Maasbach
Director |
BUY
Open market or private purchase
|
Direct | 1,000 Added 50.0% |
$17,550
$17.55 p/Share
|
Oct 01
2020 |
|
CBIO
|
Errol B Desouza
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,125 Added 14.97% |
-
|
Oct 01
2020 |
|
CBIO
|
Andrea Hunt |
BUY
Grant, award, or other acquisition
|
Direct | 2,761 Added 19.18% |
-
|
Oct 01
2020 |
|
CBIO
|
Augustine Lawlor |
BUY
Grant, award, or other acquisition
|
Direct | 5,014 Added 50.0% |
-
|
Oct 01
2020 |
|
CBIO
|
Geoffrey M.D. Ling
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,616 Added 22.04% |
-
|
Oct 01
2020 |
|
CBIO
|
Eddie Williams
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,380 Added 7.96% |
-
|
Oct 01
2020 |
|
SFE
|
Eric Salzman
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 75,000 Added 41.62% |
-
|
Oct 01
2020 |
|
SFE
|
Eric Salzman
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 3,333 Added 9.94% |
-
|
Oct 01
2020 |
|
VAPO
|
Anthony L. Arnerich
Director |
SELL
Open market or private sale
|
Indirect | 20,689 Reduced 0.77% |
$599,981
$29.0 p/Share
|
Oct 01
2020 |
|
VAPO
|
Anthony L. Arnerich
Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect | 42,857 Added 1.57% |
$599,998
$14.0 p/Share
|
Oct 01
2020 |
|
VAPO
|
Nicholas T. Walrod
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 20,689 Reduced 0.77% |
$599,981
$29.0 p/Share
|
Oct 01
2020 |
|
VAPO
|
Nicholas T. Walrod
> 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect | 42,857 Added 1.57% |
$599,998
$14.0 p/Share
|
Oct 01
2020 |
|
VAPO
|
3x5 Partners, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 20,689 Reduced 1.14% |
$599,981
$29.0 p/Share
|
Oct 01
2020 |
|
VAPO
|
3x5 Partners, LLC
> 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect | 42,857 Added 2.31% |
$599,998
$14.0 p/Share
|
Oct 01
2020 |
|
PESI
|
Thomas Bostick
Director |
BUY
Grant, award, or other acquisition
|
Direct | 855 Added 50.0% |
$4,523
$5.29 p/Share
|
Oct 01
2020 |
|
PESI
|
Joseph Timothy Grumski
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,702 Added 25.52% |
$9,004
$5.29 p/Share
|
Oct 01
2020 |
|
PESI
|
Joe Reeder
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,702 Added 0.88% |
$9,004
$5.29 p/Share
|
Oct 01
2020 |
|
PESI
|
Larry Shelton
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,028 Added 1.61% |
$10,728
$5.29 p/Share
|
Oct 01
2020 |
|
PESI
|
Zach Paul Wamp
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,106 Added 5.43% |
$5,851
$5.29 p/Share
|
Oct 01
2020 |
|
PESI
|
Mark A Zwecker
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,783 Added 0.94% |
$9,432
$5.29 p/Share
|
Oct 01
2020 |
|
AEYE
|
Jamil A. Tahir |
BUY
Grant, award, or other acquisition
|
Direct | 1,372 Added 4.57% |
-
|
Oct 01
2020 |
|
AEYE
|
Marc Lehmann |
BUY
Grant, award, or other acquisition
|
Direct | 653 Added 0.68% |
-
|
Oct 01
2020 |
|
AEYE
|
Anthony L Coelho |
BUY
Grant, award, or other acquisition
|
Direct | 653 Added 1.06% |
-
|
Oct 01
2020 |
|
BDTX
|
David M. Epstein |
SELL
Open market or private sale
|
Direct | 12,000 Reduced 1.64% |
$363,960
$30.33 p/Share
|
Oct 01
2020 |
|
BDTX
|
David M. Epstein |
BUY
Exercise of conversion of derivative security
|
Direct | 3,000 Added 0.41% |
$19,260
$6.42 p/Share
|
Oct 01
2020 |
|
CDZI
|
Murray H Hutchison
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,254 Added 1.97% |
$12,502
$9.97 p/Share
|
Oct 01
2020 |
|
CDZI
|
Geoffrey T Grant
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,254 Added 1.28% |
$12,502
$9.97 p/Share
|
Oct 01
2020 |
|
CDZI
|
Richard Nevins
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,254 Added 5.29% |
$12,502
$9.97 p/Share
|
Oct 01
2020 |
|
CTO
|
Christopher W Haga |
BUY
Grant, award, or other acquisition
|
Direct | 360 Added 7.96% |
$15,876
$44.1 p/Share
|
Oct 01
2020 |